Pardeep Nijhawan

Insider Reports History

Reporting-owner location: Markham
Latest reporting-owner signature: /s/ Peter J. Weiler, Attorney-in-Fact for Pardeep Nijhawan
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Pardeep Nijhawan

Form 4 holding Chief Executive Officer, Director, 10%+ Owner

Edesa Biotech, Inc.

Security class: Common Shares
Shares / value: 899,100
Estimated value: $7,309,683
Report date: 01 Sep 2026
Price: $8.13
Ownership: Direct

Form 4 holding Chief Executive Officer, Director, 10%+ Owner

Edesa Biotech, Inc.

Security class: Common Shares
Shares / value: 402,702
Estimated value: $3,273,967
Report date: 01 Sep 2026
Price: $8.13
Ownership: Held by Pardeep Nijhawan Medicine Professional Corporation

Form 4 holding Chief Executive Officer, Director, 10%+ Owner

Edesa Biotech, Inc.

Security class: Common Shares
Shares / value: 53,104
Estimated value: $431,735
Report date: 01 Sep 2026
Price: $8.13
Ownership: Held by 1968160Ontario Inc.

Form 4 holding Chief Executive Officer, Director, 10%+ Owner

Edesa Biotech, Inc.

Security class: Common Shares
Shares / value: 32,609
Estimated value: $265,111
Report date: 01 Sep 2026
Price: $8.13
Ownership: Held by The New Nijhawan Family Trust 2015

Form 4 holding Chief Executive Officer, Director, 10%+ Owner

Edesa Biotech, Inc.

Security class: Common Shares
Shares / value: 32,013
Estimated value: $260,265
Report date: 01 Sep 2026
Price: $8.13
Ownership: Held by The Digestive Health Clinic Inc.

Form 4 holding Chief Executive Officer, Director, 10%+ Owner

Edesa Biotech, Inc.

Security class: Common Shares
Shares / value: 53,104
Estimated value: $75,407
Report date: 01 Apr 2026
Price: $1.42
Ownership: Held by 1968160 Ontario Inc.

Insider Reports Filed by Pardeep Nijhawan

4 EDSA

Edesa Biotech, Inc.

Report period: 01 Sep 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 01 Sep 2026, 18:12
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 03 Aug 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 04 Aug 2026, 17:02
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 02 Jul 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 02 Jul 2026, 17:05
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 16 Jun 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 16 Jun 2026, 17:03
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 01 Jun 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 01 Jun 2026, 17:00
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 27 May 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 29 May 2026, 17:00
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 01 May 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 01 May 2026, 21:01
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 01 Apr 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 10 Apr 2026, 17:02
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 10 Mar 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 10 Mar 2026, 17:02
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 05 Mar 2026
Transactions: 1
Transaction value: +$39,000
Accepted by SEC: 06 Mar 2026, 17:01
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 04 Mar 2026
Transactions: 1
Transaction value: +$42,560
Accepted by SEC: 05 Mar 2026, 17:01
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 03 Mar 2026
Transactions: 1
Transaction value: +$36,300
Accepted by SEC: 04 Mar 2026, 17:01
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 02 Mar 2026
Transactions: 2
Transaction value: +$6,280
Accepted by SEC: 03 Mar 2026, 17:00
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 26 Feb 2026
Transactions: 3
Transaction value: +$99,176
Accepted by SEC: 02 Mar 2026, 17:05
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 19 Feb 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 02 Mar 2026, 17:01
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 02 Feb 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 02 Feb 2026, 17:01
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 05 Jan 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 05 Jan 2026, 21:00
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 01 Dec 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 02 Dec 2025, 18:01
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 03 Nov 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 06 Nov 2025, 18:13
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 02 Oct 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 03 Oct 2025, 16:31
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 11 Sep 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 12 Sep 2025, 21:00
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 01 Aug 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 04 Aug 2025, 21:30
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 02 Jul 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 02 Jul 2025, 21:01
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 29 May 2025
Transactions: 2
Transaction value: $0
Accepted by SEC: 02 Jun 2025, 21:21
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 02 May 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 06 May 2025, 17:28
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 01 Apr 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 03 Apr 2025, 17:25
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 03 Mar 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 03 Mar 2025, 20:00
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 12 Feb 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 14 Feb 2025, 17:01
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 03 Feb 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 04 Feb 2025, 19:32
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 06 Jan 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 06 Jan 2025, 18:01
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 02 Dec 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 03 Dec 2024, 21:08
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 12 Nov 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 12 Nov 2024, 21:29
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 30 Oct 2024
Transactions: 2
Transaction value: $0
Accepted by SEC: 01 Nov 2024, 20:49
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 02 Oct 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 02 Oct 2024, 21:30
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 03 Sep 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 03 Sep 2024, 20:00
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 01 Aug 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 02 Aug 2024, 21:01
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 02 Jul 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 03 Jul 2024, 21:00
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 03 Jun 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 04 Jun 2024, 21:01
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 01 May 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 01 May 2024, 21:30
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 01 Apr 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 02 Apr 2024, 19:02
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 25 Mar 2024
Transactions: 1
Transaction value: +$20,000
Accepted by SEC: 25 Mar 2024, 19:00
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 01 Mar 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 01 Mar 2024, 18:20
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 01 Feb 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 02 Feb 2024, 21:30
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 08 Jan 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 12 Jan 2024, 17:30
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 04 Aug 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 04 Aug 2023, 16:18
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4/A EDSA

Edesa Biotech, Inc.

Report period: 20 Jul 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 24 Jul 2023, 16:45
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 02 Nov 2022
Transactions: 6
Transaction value: +$513,590
Accepted by SEC: 04 Nov 2022, 15:27
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 30 Jun 2022
Transactions: 1
Transaction value: +$32,078
Accepted by SEC: 05 Jul 2022, 13:38
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 27 May 2022
Transactions: 1
Transaction value: +$9,599
Accepted by SEC: 31 May 2022, 09:00
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 24 May 2022
Transactions: 1
Transaction value: +$3,600
Accepted by SEC: 25 May 2022, 12:13
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 31 Mar 2022
Transactions: 1
Transaction value: +$5,972
Accepted by SEC: 01 Apr 2022, 10:56
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 30 Mar 2022
Transactions: 1
Transaction value: +$6,098
Accepted by SEC: 31 Mar 2022, 10:52
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 29 Mar 2022
Transactions: 1
Transaction value: +$6,034
Accepted by SEC: 30 Mar 2022, 12:47
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 18 Mar 2022
Transactions: 1
Transaction value: +$7,699
Accepted by SEC: 21 Mar 2022, 10:27
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 17 Mar 2022
Transactions: 2
Transaction value: +$6,522
Accepted by SEC: 18 Mar 2022, 11:26
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 15 Mar 2022
Transactions: 1
Transaction value: +$5,598
Accepted by SEC: 16 Mar 2022, 11:17
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 11 Mar 2022
Transactions: 2
Transaction value: +$21,652
Accepted by SEC: 14 Mar 2022, 13:59
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 09 Mar 2022
Transactions: 1
Transaction value: +$4,570
Accepted by SEC: 10 Mar 2022, 10:10
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 EDSA

Edesa Biotech, Inc.

Report period: 28 Feb 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 07 Mar 2022, 18:37
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

Insider Reports History

Continue from this owner filing history

Reported holdings for Pardeep Nijhawan

Insider Reports Filed by Pardeep Nijhawan